# Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

> **NCT01620788** · PHASE3 · SUSPENDED · sponsor: **EMS** · enrollment: 636 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Indapamide / Losartan
- **DRUG:** Indapamide / Losartan
- **DRUG:** Hyzaar®
- **DRUG:** Hyzaar®

## Key facts

- **NCT ID:** NCT01620788
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-11-27
- **Primary completion:** 2023-07
- **Final completion:** 2023-10
- **Target enrollment:** 636 (ESTIMATED)
- **Why stopped:** Substancial amendment
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620788, "Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01620788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*